期刊文献+

64例上皮性卵巢癌的临床及预后分析 被引量:2

The clinical and prognostic analysis of 64 cases with epithelial ovarian cancer
下载PDF
导出
摘要 目的:探讨影响上皮性卵巢癌预后的因素。方法:对64例卵巢上皮性癌的病例资料进行回顾性分析, 26例早期(Ⅰ-Ⅱ)病人以全子宫切除加双附件切除为主,38例晚期(Ⅲ级及以上)以肿瘤减灭术为主,术后化疗以 CAP方案为主(环磷酰胺、阿霉素、顺氯氨铂)。结果:早期患者存活率明显高于晚期患者(P<0.01)。38例晚期患者中,理想的肿瘤减灭术(无残灶或残灶<2 cm)者存活率明显高于不理想的肿瘤减灭术(残灶≥2 cm)者(P <0.05)。术后化疗次数≥6次者与<6次者存活率差异有统计学意义(P<0.05)。分化程度对预后有明显影响 (P<0.05),但年龄及病理类型对预后影响差异无统计学意义(P>0.05)。肿瘤的临床分期、残灶大小及化疗次数对预后影响较大。结论:早期诊断、首次手术彻底以及化疗疗程≥6次是改善上皮性卵巢癌预后的关键。 Objective: To investigate the prognostic factors of epithelial ovarian carcinoma. Methods.. The clinical data and follow-up data of 64 patients with epithelial ovarian carcinoma who were treated in our hospital between Feb 1995 to Feb 2005 were retrospectively studied. Results.. The median survival of 64 patients with epithelial ovarian carcinoma was 26 months. The survival rate of patients in early stage (FIGO stage Ⅰ and Ⅱ ) was significantly higher than that of patients in advanced stage (FIGO stage Ⅲ ) (P〈 0.01). All patients received surgical therapy. Among advanced stage of patients, good cytoreductive surgery (no residue or residue〈2 cm) were performed in 20 patients and their survival rate was significantly higher than these of 18 unsuccessful cases(residue≥2 cm ), 26 patients undertook 6 or more courses of chemotherapy their survival rate was also significantly higher than that of 38 patients who undertook less than 6 courses. The survival rate of patients with different pathological grade had significant difference (P〈0.05). Clinical stage, size of residue and the courses of chemotherapy were independent prognostic factors. Conclusion: Early diagnosis, primary optimal cytoreductive surgery and 6 or more courses of chemotheraphy might improve the survival of patients with epithelial ovarian carcinoma.
出处 《新疆医科大学学报》 CAS 2006年第3期245-247,共3页 Journal of Xinjiang Medical University
关键词 上皮性卵巢癌 临床分期 手术 化疗 预后 epithelial ovarian carcinoma stage operation chemotheraphy, prognosis
  • 相关文献

参考文献5

  • 1王桂芳,侍庆.卵巢上皮性癌142例治疗与预后因素分析[J].实用妇产科杂志,2000,16(3):148-150. 被引量:8
  • 2Dupont NC,BermanML.Surgical management of epithelial ovarian cancer:a review of the literature[J].Minerva Ginecol,2004,56(6):547-556.
  • 3Lyngstadaas A,Ekanger R,Hagen B.Treatment of primary ovarian cancer:a systematic review[J].Tidsskr Nor Laegeforen,2005,125(3):278-281.
  • 4邢军,肖永红.卵巢上皮性癌生存预后临床分析[J].河北医学,1999,5(2):3-5. 被引量:2
  • 5Bertalsen KA.Prospective randomized comparison of 6 and 12 cycles of cyclophosphamide adiramycin and ciplatin in advanced epithelia ovarian cancer:A Danish ovarian study group trial (DACOVA)[J].Gynecol Oncol,1993,49:30.

二级参考文献11

  • 1李孟达,黄欣.中、晚期卵巢癌综合治疗疗效及影响因素的分析[J].中华妇产科杂志,1996,31(10):621-623. 被引量:35
  • 2连利娟 林巧稚.妇科肿瘤学(第2版)[M].北京:人民卫生出版社,1994.707-719.
  • 3魏丽惠.卵巢上皮性癌115例的治疗与预后[J].中华妇产科杂志,1997,8:476-479.
  • 4王淑贞主编.实用妇产科学.第12版.北京:人民卫生出版社,1991,686-721.
  • 5Morrowcp Malignant and borderline epithelial tumors of ovary. In coppleson M, ed.Gynecologic oncology. Isted. London : Churchill,1981,655~675.
  • 6Young RC, Walton LA, Ellenberg ss, et al. Adjuvant therapy in stage I and Ⅱepithelial ovarian cancer:result of two prospective randomized trials. N Eng I J Med,1990,15:1021.
  • 7FIGO,Cancer committee. Annual report on the results of treatment in gynecologiccancer. Stockholm,1988,21:114.
  • 8Friedman-RL; EisenRop-SM; Wang-HJ, et al. Second-look Laparotomy for ovarian cancerprovides reliable prognostic information and improves survival, Gynecol-oncol. oct; 1997.67(1):88~94.
  • 9Griffiths CT. Carinoma of the ovary: surgical objectives. In:sharPF, south WP, eds.Ovarian cancer: theway ahead. Lonton:chameleon Press, 1987,235~237.
  • 10Dembo AT,Dary MLJ,Stenwing AE,et al. Prognostic factors in patients with stage Iepithelial ovarian cancer. Obstet Gynecol,1990,75:263.

共引文献8

同被引文献44

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部